The cleavage of aryl
methyl ethers is a common reaction in chemistry requiring rather harsh
conditions; consequently, it is prone to undesired reactions and lacks
regioselectivity. Nevertheless,
O
-demethylation of
aryl methyl ethers is a tool to valorize natural and pharmaceutical
compounds by deprotecting reactive hydroxyl moieties. Various oxidative
enzymes are known to catalyze this reaction at the expense of molecular
oxygen, which may lead in the case of phenols/catechols to undesired
side reactions (e.g., oxidation, polymerization). Here an oxygen-independent
demethylation via methyl transfer is presented employing a cobalamin-dependent
veratrol-
O
-demethylase (vdmB). The biocatalytic demethylation
transforms a variety of aryl methyl ethers with two functional methoxy
moieties either in 1,2-position or in 1,3-position. Biocatalytic reactions
enabled, for instance, the regioselective monodemethylation of substituted
3,4-dimethoxy phenol as well as the monodemethylation of 1,3,5-trimethoxybenzene.
The methyltransferase vdmB was also successfully applied for the regioselective
demethylation of natural compounds such as papaverine and
rac
-yatein. The approach presented here represents an alternative
to chemical and enzymatic demethylation concepts and allows performing
regioselective demethylation in the absence of oxygen under mild conditions,
representing a valuable extension of the synthetic repertoire to modify
pharmaceuticals and diversify natural products.